DYN- Dyne Therapeutics, Inc.

Name: Dyne Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Dyne Therapeutics, Inc. (DYN) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. DYN is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Kersten Dirk	5.28M	$110.10M	-
Dir	Rhodes Jason P	1.16M	$24.19M	-
CEO	Cox John	368.2K	$7.68M	-2,683
Other	Kerr Douglas	169.2K	$3.53M	-887
Other	Friedl-Naderer Johanna	154.2K	$3.22M	-145

Activity

Buys and sells only

Transactions

10 filings · page 14

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 12, 2023	McNeill Jonathan55	Chief Business Officer	Sell	1,266	$10.41	$13,179.06	-2.0%	+10.1%	+229.3%
Sep 12, 2023	High Susanna Gatti66	Chief Operating Officer	Sell	1,635	$10.41	$17,020.35	-1.5%	+10.1%	+229.3%
Sep 12, 2023	Brumm Joshua T54	See Remarks	Sell	7,672	$10.41	$79,865.52	-3.0%	+10.1%	+229.3%
Sep 12, 2023	Beskrovnaya Oxana58	Chief Scientific Officer	Sell	1,484	$10.41	$15,448.44	-1.7%	+10.1%	+229.3%
Jun 15, 2023	Scalzo Richard William58	See Remarks	Sale+OE	51,390	$12.71	$653,177.70	-25.5%	-23.4%	+173.3%
Jun 13, 2023	High Susanna Gatti66	Chief Operating Officer	Sell	1,625	$12.43	$20,198.75	-1.5%	-13.1%	+156.5%
Jun 13, 2023	Farwell Wildon55	Chief Medical Officer	Sell	1,698	$12.43	$21,106.14	-1.8%	-13.1%	+156.5%
Jun 13, 2023	Beskrovnaya Oxana58	Chief Scientific Officer	Sell	1,475	$12.43	$18,334.25	-1.7%	-13.1%	+156.5%
Jun 13, 2023	McNeill Jonathan55	See Remarks	Sell	2,259	$12.68	$28,649.37	-1.7%	-13.1%	+156.5%
Jun 12, 2023	Brumm Joshua T54	See Remarks	Sale+OE	325,330	$12.90	$4,195,796.64	-23.2%	-10.7%	+147.3%

← PrevPage 14Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC